Course Experts: Lucy Yu, PharmD, BCPS, BCOP and Gayle Blouin, PharmD, BCOP

Course Description: This course reviews platinum resistant ovarian cancer, key trial endpoints related to approval of mirvetuximab soravtansine (MIRV), prevention of common ocular toxicities, and application of current evidence to patient care and decision-making.

Course Experts: Madeline Schultze, PharmD

Course Description: This course reviews biomarker results to guide targeted treatment decisions in gastric cancer and differentiates treatment approaches for early stage and advanced gastric cancer. This course allows learners to evaluate recently approved clinical trial data and develop evidence-based treatment plans for patients with gastric cancer.

Course Experts: Iman Suliman, PharmD, BCACP

Course Description: This course introduces the Orange Book, a palliative care symptom management guide by Dana-Farber Cancer Institute and Brigham & Women’s Hospital, focusing on assessing and treating fatigue, insomnia, mucositis, secretions, and small bowel obstruction.

Course Experts: Iman Suliman, PharmD, BCACP and Addison Sember, PharmD

Course Description: This course introduces the Orange Book, a palliative care symptom management guide by Dana-Farber Cancer Institute and Brigham & Women’s Hospital, focused on assessing and treating appetite stimulation, constipation, delirium, diarrhea, and dyspnea.

Course Experts: Jason Maille, PharmD

Course Description: This course examines QT prolongation and Torsades de Pointes in oncology patients, emphasizing risk stratification, QTc calculation methods, and application of guideline-based mitigation strategies.

Course Experts: Brandon Farino, PharmD

Course Description: This course reviews the types of information that can be stored and conveyed via barcoding technology, and the role and limitations of barcoding technology in preventing medication errors. It also describes the current capacity of radio frequency identification (RFID) technology to prevent medication errors.

Course Experts: Addison Sember, PharmD and Ben Kematick, PharmD, BCACP

Course Description: This pharmacy law course outlines mitigation and communication strategies when providing care for patients with concomitant substance use disorder. Updates in medication delivery regulations and the Department of Health & Human Services opioid treatment program are reviewed.

Course Experts: Jessica Warner, PharmD, BCPS

Course Description: This course provides pharmacists and pharmacy technicians with an overview of dietary supplement use among patients with cancer, including common usage patterns, potential safety concerns, and adverse effects. Participants will also learn the Dana-Farber Zakim model for evaluating supplement safety to support informed, evidence-based patient care.

Course Experts: Victoria Grant, PharmD, BCIDP

Course Description: This course outlines the purpose of antimicrobial stewardship, how its goals and regulatory requirements differ between inpatient and outpatient settings, and the unique importance and challenges of antimicrobial stewardship in oncology patients.

Course Experts: Abigail Horan, PharmD

Course Description: This courses evaluates pivotal trials for FDA-approved emerging therapies for acute myeloid leukemia (AML) and identifies adverse drug reactions in AML treatment. It reviews treatment with menin inhibitors and general clinical pearls when generating treatment for patients with AML.

Course Experts: Sylvia Truong, PharmD; Eno Inyang, PharmD, BCPS; Lara Abousamra, PharmD, BCPS

Course Description: This course reviews the role of hematopoietic stem cell transplantation (HSCT) in the management of hematologic malignancies, with a focus on patient selection and evidence-based post-transplant maintenance strategies. Learners will evaluate clinical trial data, guideline recommendations, and treatment-related toxicities to optimize maintenance therapy f...

Course Experts: Yong Jun (Eric) Bae, PharmD, MBA, BCOP and Emily Tiao, PharmD, BCOP

Course Description: This course addresses risk groups and therapeutic aims in MDS, and reviews recent literature and related medication management on novel agents in low-risk MDS.